L505-0425 Screening compound: N-[(2-chlorophenyl)methyl]-2-[2-(5-ethyl-1,3,4-oxadiazol-2-yl)-1H-pyrrol-1-yl]acetamide

L505-0425 Screening compound: N-[(2-chlorophenyl)methyl]-2-[2-(5-ethyl-1,3,4-oxadiazol-2-yl)-1H-pyrrol-1-yl]acetamide
L505-0425 Screening compound: N-[(2-chlorophenyl)methyl]-2-[2-(5-ethyl-1,3,4-oxadiazol-2-yl)-1H-pyrrol-1-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L505-0425
N-[(2-chlorophenyl)methyl]-2-[2-(5-ethyl-1,3,4-oxadiazol-2-yl)-1H-pyrrol-1-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L505-0425

Molecular Formula

C17H17ClN4O2 (C17 H17 ClN4 O2)

Compound Name

N-[(2-chlorophenyl)methyl]-2-[2-(5-ethyl-1,3,4-oxadiazol-2-yl)-1H-pyrrol-1-yl]acetamide

IUPAC name

N-[(2-chlorophenyl)methyl]-2-[2-(5-ethyl-134-oxadiazol-2-yl)-1H-pyrrol-1-yl]acetamide

SMILES

CCc1nnc(-c2cccn2CC(NCc(cccc2)c2Cl)=O)o1

InChI

InChI=1S/C17H17ClN4O2/c1-2-16-20-21-17(24-16)14-8-5-9-22(14)11-15(23)19-10-12-6-3-4-7-13(12)18/h3-9H,2,10-11H2,1H3,(H,19,23)

InChI Key

CPLFQUNDFHCLLT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27459017

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

344.8

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.095

Distribution Coefficient, logD

3.095

Water Solubility, LogSw

-3.36

Polar Surface Area

56.481

Acid Dissociation Constant (pKa)

12.91

Base Dissociation Constant (pKb)

-1.79

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.50

L505-0425 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with L505-0425 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L505-0425?
Check Price and Availability of L505-0425, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L505-0425 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L505-0425
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L505-0425
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L505-0425 available by request